title: Effect of pinacidil on renal haemodynamics, tubular function and plasma levels of angiotensin II, aldosterone and atrial natriuretic peptide in healthy man.
abstract: The effects of pinacidil on renal haemodynamics, tubular function evaluated by the lithium clearance technique and the plasma levels of angiotensin II (Ang II), aldosterone (Aldo) and atrial natriuretic peptide (ANP) have been evaluated in 12 healthy volunteers given pinacidil 0.1 mg/kg IV in comparison with a placebo given to 13 different healthy volunteers. Pinacidil induced significant reductions in glomerular filtration rate (-5%), renal plasma flow (-12%), urine output (-35%), urinary sodium excretion (-20%), and the fractional excretion of sodium (-17%) and potassium (-29%). Lithium clearance and proximal and distal absolute and fractional reabsorption of sodium were not significantly changed. Ang II and Aldo were significantly increased (80% and 115%, respectively) and ANP was unchanged. The mean arterial blood pressure was not significantly changed by pinacidil, but the heart rate was increased (22%). It is concluded that bolus IV injection of pinacidil in healthy subjects reduced renal blood flow, urine volume and the urinary excretion of sodium and potassium, whereas segmental tubular function was unchanged. The increase in heart rate and activation of the renin-angiotensin-aldosterone system are most likely to be secondary to stimulation of the sympathetic nervous system caused by the vasodilator effect of pinacidil.
authors.affiliation: Department of Medicine and Nephrology C, Skejby Hospital University Hospital, Aarhus, Denmark.
authors.forename: C B
authors.initials: CB
authors.lastname: Nielsen
authors.forename: E B
authors.initials: EB
authors.lastname: Pedersen
mesh_terms: D000328:Adult; D000450:Aldosterone / Q000097:blood*; D000804:Angiotensin II / Q000097:blood* / Q000187:drug effects; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000494:pharmacology*; D009320:Atrial Natriuretic Factor / Q000097:blood* / Q000187:drug effects; D002986:Clinical Trials as Topic; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006146:Guanidines / Q000008:administration & dosage / Q000494:pharmacology*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D007684:Kidney Tubules / Q000187:drug effects* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D020110:Pinacidil; D017595:Renal Plasma Flow / Q000187:drug effects*; D016037:Single-Blind Method
chemical_list: D000959:Antihypertensive Agents; D006146:Guanidines; D000804:Angiotensin II; D000450:Aldosterone; D020110:Pinacidil; D009320:Atrial Natriuretic Factor